• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Personalis, Inc. - Common Stock (NQ:PSNL)

    10.54 +0.79 (+8.10%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,823,116
    Open 10.00
    Bid (Size) 10.50 (100)
    Ask (Size) 10.65 (1,000)
    Prev. Close 9.750
    Today's Range 9.885 - 10.58
    52wk Range 3.840 - 12.53
    Shares Outstanding 48,518,901
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis CEO Sells 100,000 Company Shares Worth $1.1 Million. What Does That Mean for Investors? ↗
    This cancer genomics specialist, serving major biopharma and research clients, reported a notable insider sale in its latest SEC filing. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +34.3%
    +34.3%
    1 Month
    +32.6%
    +32.6%
    3 Month
    +45.2%
    +45.2%
    6 Month
    +23.3%
    +23.3%
    1 Year
    +64.2%
    +64.2%

    More News

    Read More
    News headline image
    Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation from TRACERx Consortium
    From Personalis, Inc.
    Via Business Wire
    Personalis (NASDAQ:PSNL) Volume Surge Can't Mask Q1 Miss as Losses Widen ↗
    Via Chartmill
    Personalis Inc (NASDAQ:PSNL) Reports Mixed Q4 2025 Results and Aggressive 2026 Growth Outlook ↗
    Via Chartmill
    News headline image
    Personalis Secures Fourth Medicare Coverage Decision for NeXT Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monitoring
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis to Participate in Upcoming Investor Events
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis Receives Medicare Coverage for NeXT Personal® for Immunotherapy Monitoring Across Late-stage Solid Tumors
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Personalis (PSNL) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Personalis Reports First Quarter Results and Recent Highlights
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis to Announce First Quarter 2026 Financial Results
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis to Participate in the 25th Annual Needham Virtual Conference
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal®
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Lightspeed Makes a Big Bet on Self-Driving Trucks, Loading Up on 7 Million Shares of Kodiak AI (KDK) ↗
    Via The Motley Fool
    Topics Artificial Intelligence Regulatory Compliance
    News headline image
    Lightspeed Management Made a Huge Bet on Navan (NAVN) With a Purchase of 49.9 Million Shares ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Personalis (PSNL) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis to Participate in the TD Cowen 46th Annual Healthcare Conference
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis to Announce Fourth Quarter and Full Year 2025 Financial Results
    From Personalis, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Personalis, Inc. - Common Stock publicly traded?
    Yes, Personalis, Inc. - Common Stock is publicly traded.
    What exchange does Personalis, Inc. - Common Stock trade on?
    Personalis, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Personalis, Inc. - Common Stock?
    The ticker symbol for Personalis, Inc. - Common Stock is PSNL on the Nasdaq Stock Market
    What is the current price of Personalis, Inc. - Common Stock?
    The current price of Personalis, Inc. - Common Stock is 10.54
    When was Personalis, Inc. - Common Stock last traded?
    The last trade of Personalis, Inc. - Common Stock was at 06/18/26 04:00 PM ET
    What is the market capitalization of Personalis, Inc. - Common Stock?
    The market capitalization of Personalis, Inc. - Common Stock is 511.39M
    How many shares of Personalis, Inc. - Common Stock are outstanding?
    Personalis, Inc. - Common Stock has 511M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.